investment in ipo

Biotech company Dermata Therapeutics has an IPO

Biotechnology company Dermata Therapeutics, developing drugs for the treatment of skin diseases based on badyagi in 3 research phase, attracted 18 million dollars, releasing 2,6 million packages of 7 dollars - the minimum price of the stated range from 7 to 9 Dollars.

Biotech company IN8bio has an IPO

Biotechnology company IN8bio, develops allogeneic drugs for cancer treatment based on gamma-delta T cells, located in 1 research phase, attracted 40 million dollars, releasing 4 million shares in 10 dollars - the minimum price of the stated range from 10 to 12 Dollars.

Immuneering offers more shares at IPO

Preclinical Biotechnology Company Immuneering, specializing in influencing signaling pathways for the treatment of cancer and neurological diseases, attracted 113 million dollars, releasing 7,5 million shares in 15 dollars - within the stated range from 14 to 16 Dollars.

Rani Therapeutics has an IPO on 11$

Компания Rani Therapeutics, developing capsules for oral medication by swallowing, attracted 73 million dollars, releasing 6,7 million shares in 11 dollars - below the stated range from 14 to 16 Dollars. Taking into account the actual IPO price, the total diluted market value of the company was 528 million dollars.

Biotechnology company Eliem Therapeutics announces IPO terms

2 August biotech company Eliem Therapeutics, developing drugs for the treatment of disorders of nervous excitability in phase 2a research, announced the terms of the upcoming IPO. Company headquartered in Redmond, Washington State, plans to attract 81 million dollars, releasing 4,5 million shares at a price from 17 to 19 Dollars.

Publishing house IDW Media Holdings held an IPO

Comic publisher, graphic novels and art books by IDW Media Holdings 9 million dollars, releasing 2,5 million shares in 3,60 dollars - below the closing price of its OTC stock (IDWM), constituted 3,95 dollar. The company offered at 0,25 million shares more, than planned.

Scroll to Top